Welcome to our dedicated page for Momentus news (Ticker: MNTS), a resource for investors and traders seeking the latest updates and insights on Momentus stock.
Momentus Inc. reports developments in commercial space operations, satellite technology, in-space transportation, and orbital infrastructure services. The company offers satellites, satellite components, and services built around its Vigoride orbital service vehicle, including hosted payload support, last-mile satellite delivery, and in-orbit servicing capabilities for government, defense, and commercial customers.
Recurring Momentus news includes Vigoride mission launches and commissioning updates, payload operations, design-review milestones, NASA and U.S. Department of Defense contract activity, and technology demonstrations involving propulsion, communications, onboard computing, and in-space assembly. Company updates also cover shareholder communications, revenue guidance, private placements, debt retirement, balance-sheet actions, and participation in commercial space industry forums.
Momentus Inc. (NASDAQ: MNTS) reported its financial results for Q1 2022, revealing progress in launching its Vigoride spacecraft. The spacecraft is now at Cape Canaveral for integration with a SpaceX Falcon 9 rocket, with the launch targeted for this month. The company successfully conducted extensive ground tests and signed agreements for four additional SpaceX missions through 2023. Momentus has also secured requisite government licenses and approvals, bolstering its regulatory compliance. Key talent has been added to strengthen the team, enhancing its competitive edge in the aerospace sector.
Momentus Inc. (NASDAQ: MNTS) announces the arrival of its Vigoride orbital transfer vehicle at Cape Canaveral, Florida, in preparation for its inaugural launch on the Falcon 9 rocket. The mission aims to test Vigoride in space, rectify any issues encountered, and incorporate lessons learned into future missions. Momentus is set to generate revenue by transporting customer payloads from clients including FOSSA Systems and Orbit NTNU. The launch is scheduled for May 2022, marking a significant step in providing in-space infrastructure services.
Momentus (NASDAQ: MNTS) announced a favorable FAA payload review for its inaugural Vigoride orbital transfer vehicle flight, scheduled for SpaceX's Transporter-5 mission this month. This decision concludes the final regulatory requirements, following the recent FCC license and NOAA updates, allowing communication with the spacecraft. The FAA's approval reflects progress in addressing national security concerns. The mission aims to transport customer payloads and test Vigoride in orbit, though revenue generation is secondary to operational learning.
Momentus Inc. (NASDAQ: MNTS) announced the appointment of Charles Chase, Nick Zello, and Gary Bartmann as Vice Presidents of Engineering, Operations, and Supply Chain, respectively. These leaders bring extensive aerospace experience, focusing on innovation and strategy development. CEO John Rood emphasized their roles in transitioning the company from development to production, particularly with the upcoming launch of their Vigoride vehicle, powered by a water plasma-based propulsion system. This move aims to enhance Momentus' capabilities in the commercial space sector.
Momentus Inc. (NASDAQ: MNTS) has received an FCC license for its Vigoride orbital transfer vehicle, set to launch on SpaceX's Transporter-5 mission in May 2022. This license permits communication with Vigoride in Low Earth Orbit, marking significant regulatory progress. The FAA's payload review is the last step before launch, ensuring safety and compliance. During this mission, Momentus will transport customer payloads and gather data to improve future operations. The spacecraft successfully completed vibration testing, indicating readiness for the launch environment.
Momentus Inc. (NASDAQ: MNTS) announced it will release its financial results for Q1 2022 on May 10, 2022, after market close. A conference call to discuss these results will occur at 5:00 p.m. ET. Participants can join by calling +1 (800) 348-8613, with an International option at +1 (973) 528-0141. Momentus focuses on providing in-space infrastructure services, targeting the launch of its Vigoride vehicle to Low Earth Orbit as early as May 2022, pending necessary government licenses.
Momentus Inc. (NASDAQ: MNTS) announced the successful completion of vibration testing of its Vigoride orbital transfer vehicle at the National Technical Systems lab in Southern California. This milestone is part of Vigoride's ground test campaign, preparing it for its first mission on the SpaceX Transporter-5 mission, targeted for launch no earlier than May 2022, pending government licenses. The mission aims to deliver customer payloads to orbit and test Vigoride's functionality, with the potential to generate initial revenue.
Momentus Inc. (NASDAQ: MNTS) has secured multiple launch agreements with SpaceX, establishing a flight schedule through 2023. These agreements include slots for the upcoming Transporter missions, enhancing Momentus' launch cadence as it prepares to introduce its Vigoride orbital transfer vehicle. The company is currently completing testing phases for Vigoride, including Thermal Vacuum Testing and vibration testing. The inaugural flight is expected to occur in June 2022, pending government approvals.
Takeda proposes new candidates for independent external directors at its upcoming shareholders' meeting on June 29, 2022. The candidates, Kimberly A. Reed and John Maraganore, will replace retiring directors Toshiyuki Shiga and Shiro Kuniya. Additionally, Masami Iijima is nominated as the new chair of the Board Meetings, succeeding Masahiro Sakane. This move aims to enhance governance and diversity within the board. All current members will also be proposed for re-election.
Momentus Inc. (NASDAQ: MNTS) has completed Thermal Vacuum Testing (TVAC) on its Vigoride vehicle, simulating space conditions in preparation for its inaugural mission. The company received NOAA approval to modify its Vigoride license, enhancing readiness for the mission targeted in June 2022. Vigoride is also set for vibration testing, the last phase before launch. CEO John Rood highlights the progress made since the company's public debut, emphasizing ongoing testing and licensing activities as part of the normal operational cadence.